Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1Leukemia 1Hodgkin Disease 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

venetoclax 5Dexamethasone 5Cytarabine 3Cyclophosphamide 3Vincristine 2Decitabine 2trametinib 1ruxolitinib 1pegaspargase 1nilotinib 1navitoclax 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1blinatumomab 1Vorinostat 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Dasatinib 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Spinal Puncture × Clear all
NCT03504644 2026-05-13

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Eastern Cooperative Oncology Group

Phase 1/2 Active not recruiting
40 enrolled 18 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡